Only qualified healthcare providers may order
Global Screening Array + Interpretation
This test analyzes a DNA sample for changes in genes associated with actionable results for a patient. Most of the 59 genes are associated with Carrier Status of either a hereditary form of cardiovascular disease or cancer risk. Cancer risks include breast, ovarian, colon, thyroid, and other types of cancer. Other genes included in the screening are associated with Pharmacogenetics—certain reactions or non-reactions to medications and Adult-onset Actionable Variant Status for those carriers of a known hereditary rare disease.